ARCHIVES

NCI Preliminary Budge For 1979 By Mechanism

This article is from The Cancer Letter archive.

Vol. 03 No. 22 | June 3, 1977

Download PDF Visit The Full Archive

Related Articles

Weak Structure, Deficiencies, Cited In Dana-Farber Reviews

November 3, 1995

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

ACS Funds Pilot Study Of Mammography Trial

July 28, 1995

Prevention Clinical Trials Heads Greenwalk Priority Lists For ‘86

February 8, 1985

NCI Advisors Reject $30-Million Cohort Study, Approve Renewal of Phase I Clinical Trials Initiatives and American College of Radiology Imaging Network.

July 7, 2006

High-Dose Chemo Doesn’t Improve Survival In Small Cell Lung Cancer

April 25, 2008